Mansoor Raza Mirza Sera Prognostics, Inc. (SERA) insider trading activity

Mansoor Raza Mirza is of SERA PROGNOSTICS, INC.. Currently has a direct ownership of 57,740 shares of SERA, which is worth approximately $170,910. The most recent transaction as insider was on Dec 05, 2025, when has been sold 292 shares (Class A Common Stock) at a price of $3.05 per share, resulting in proceeds of $890. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.7K

1.27% 3M change

770.1% 12M change

Total Value Held $170,910

Mansoor Raza Mirza Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 05 2025	SELL Open market or private sale	$890 $3.05 p/Share	292 Reduced 0.5%	57,740 Class A Common Stock
Nov 05 2025	SELL Open market or private sale	$671 $3.04 p/Share	221 Reduced 0.38%	58,032 Class A Common Stock
Oct 06 2025	SELL Open market or private sale	$717 $3.16 p/Share	227 Reduced 0.39%	58,253 Class A Common Stock
Sep 05 2025	SELL Open market or private sale	$743 $3.35 p/Share	222 Reduced 0.38%	58,480 Class A Common Stock
Aug 05 2025	SELL Open market or private sale	$562 $2.5 p/Share	225 Reduced 0.38%	58,702 Class A Common Stock
Jul 07 2025	SELL Open market or private sale	$552 $2.36 p/Share	234 Reduced 0.4%	58,927 Class A Common Stock
Jun 06 2025	SELL Open market or private sale	$169 $1.58 p/Share	107 Reduced 0.18%	59,161 Class A Common Stock

Jun 05 2025	BUY Grant, award, or other acquisition	-	15,596 Added 20.83%	59,268 Class A Common Stock
May 08 2025	SELL Open market or private sale	$258 $2.44 p/Share	106 Reduced 0.24%	43,672 Class A Common Stock
Apr 07 2025	SELL Open market or private sale	$358 $3.35 p/Share	107 Reduced 0.24%	43,778 Class A Common Stock
Mar 06 2025	SELL Open market or private sale	$411 $4.16 p/Share	99 Reduced 0.23%	43,885 Class A Common Stock
Feb 12 2025	SELL Open market or private sale	$462 $4.58 p/Share	101 Reduced 0.23%	43,984 Class A Common Stock
Jan 27 2025	BUY Exercise of conversion of derivative security	$34,169 $0.91 p/Share	37,549 Added 46.0%	44,085 Class A Common Stock
Jan 06 2025	SELL Open market or private sale	$769 $7.69 p/Share	100 Reduced 1.51%	6,536 Class A Common Stock
Dec 06 2024	SELL Open market or private sale	$662 $7.12 p/Share	93 Reduced 1.38%	6,636 Class A Common Stock
Nov 11 2024	SELL Open market or private sale	$695 $7.32 p/Share	95 Reduced 1.39%	6,729 Class A Common Stock
Oct 07 2024	SELL Open market or private sale	$686 $7.15 p/Share	96 Reduced 1.39%	6,824 Class A Common Stock
Sep 06 2024	SELL Open market or private sale	$687 $7.16 p/Share	96 Reduced 1.37%	6,920 Class A Common Stock
Aug 07 2024	SELL Open market or private sale	$749 $7.42 p/Share	101 Reduced 1.42%	7,016 Class A Common Stock
Jun 06 2024	BUY Grant, award, or other acquisition	-	7,117 Added 50.0%	7,117 Class A Common Stock

Also insider at

KPTI

Karyopharm Therapeutics Inc. Healthcare

ACRV

Acrivon Therapeutics, Inc.

Chief Medical Officer

MRM